Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyramax in Asymptomatic P. falciparum Carriers
NCT03814616Phase 2Unknown
- Sponsor
- Shinpoong Pharma
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pyronaridine in Plasmodium falciparum malaria, sponsored by Shinpoong Pharma. Status: unknown.
02
Drugs
pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT03814616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03814616.